We are pleased to announce that Molecular Cytogenetics has received its first official Impact Factor of 2.36 in

We sincerely thank our distinguished international editorial board for their efforts on behalf of the jour-nal, and our publisher, BioMed Central, for their in-house contribution to the speed and efficiency with which manuscripts are processed. Most important of all, of course, are our authors and reviewers [1], and to them we extend our particular thanks. Since it was launched in 2008, Molecular Cytogenetics has considered 204 and published 179 articles, giving an acceptance rate of 86%. This exemplifies the journal’s inclusive editorial policy to publish manu-scripts that are scientifically sound, and not just based on perceived impact. These articles cover a wide range of topics in molecular cytogenetics, in-cluding clinical and tumor cytogenetics, interphas